GL1X · GenesisL1 explorer

MolNFT v1 · #90828 · protein

Crystal structure of serratia fonticola carbapenemase sfc-1 E166A mutant with the acylenzyme intermediate of meropenem

4EV4 · Carbapenem-hydrolizing beta-lactamase sfc-1: “Crystal structure of serratia fonticola carbapenemase sfc-1 E166A mutant with the acylenzyme intermediate of…”. X-ray diffraction, 1 ligand (MER), 1 pocket (best druggability 0.26).…

PDB
4EV4
Type
protein
Length
270 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Carbapenem-hydrolizing beta-lactamase sfc-1
EC
3.5.2.6
UniProt
Q6JP75
Ligands
MER
Pockets
1 · best druggability 0.26

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACarbapenem-hydrolizing beta-lactamase sfc-1 (EC 3.5.2.6)protein27043% helix, 16% strandQ6JP75

Ligands and binding sites

  • MER · (4R,5S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid · ligand · chains A
  • EDO · 1,2-ethanediol · additive · 4 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1570.260.7416MER

Modifications

Observed in the structure: 1 covalent, 1 disulfide, 1 modified (covalent ligand, disulfide, nonstandard).

Compared structures

  • 4EV4 · Crystal structure of serratia fonticola carbapenemase SFC-1 E166A mutant with the… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.